Neoplasia/BPH

	Tumor infiltrating B lymphocytes (TIBs) associate with poor clinical outcomes, unfavorable therapeutic benefit and immunosuppressive context in metastatic clear cell renal cell carcinoma (mccRCC) patients treated with anti-PD-1 antibody plus Axitinib. J Cancer Res Clin Oncol Lin Z, Xiao S, Qi Y, Guo J, Lu L. PMID: 38762825 [PubMed - indexed for MEDLINE]
	Contrast-enhanced ultrasound for differentiating benign from malignant focal solid renal lesions in pediatric patients. Sci Rep Fu Y, Zhong J, Tan Y, Zheng T, Liu M, Wang G. PMID: 38762673 [PubMed - indexed for MEDLINE]
	Current evidence on the relationships among five polymorphisms in the matrix metalloproteinases genes and prostate cancer risk. Sci Rep Gui J, Zhou H, Li S, Chen A, Liu Q, Zhu L, Mi Y. PMID: 38762659 [PubMed - indexed for MEDLINE]
	Da Vinci vs. Hugo RAS for robot-assisted radical prostatectomy: a prospective comparative single-center study. World J Urol Brime Menendez R, García Rojo E, Hevia Palacios V, Feltes Ochoa JA, Justo Quintas J, Lista Mateos F, Fraile A, Manfredi C, Belli S, Bozzini G, Romero Otero J. PMID: 38762627 [PubMed - indexed for MEDLINE]
	Index tumor location affected early biochemical recurrence after radical prostatectomy in patients with negative surgical margin: a retrospective study. BMC Urol Ogata Y, Akatsuka J, Endo Y, Mikami H, Yanagi M, Takeda H, Toyama Y, Yamamoto Y, Kimura G, Kondo Y. PMID: 38762458 [PubMed - indexed for MEDLINE]
	A rare case of spontaneous bladder wall abscess mimicking bladder tumour in young women. BMC Urol Alfarizi ZY, Subekti E, Danarto, Yuri P. PMID: 38762447 [PubMed - indexed for MEDLINE]
	Development and Validation of a Survey to Assess Sexual Health in Female Partners of Patients with Prostate Cancer. Eur Urol Oncol Loeb S, Gupta N, Wittmann D, Nelson CJ, Mulhall JP, Salter CA, Byrne N, Sanchez Nolasco T, Zebib L, Garrett L, Schofield E. PMID: 38762369 [PubMed - as supplied by publisher]
	Phase 2 Study of Preoperative Tislelizumab in Combination with Low-dose Nab-Paclitaxel in Patients with Muscle-invasive Bladder Cancer. Eur Urol Oncol Wu Z, Zhao G, Zhang Z, Shen C, Wang L, Xu G, Zhao Y, Liang R, Li C, Liu H, Wang H, Dong H, Fu H, Li M, Li H, Zhuang Y, Da L, Huang S, Jia K, Chen H, Bai Y, Guo S, Cheng H, Wang H, Wang H, Niu Y, Hu H. PMID: 38762368 [PubMed - as supplied by publisher]
	Strategies of Bladder Reconstruction after Partial or Radical Cystectomy for Bladder Cancer. Mol Biotechnol Zeng XX, Wu Y. PMID: 38761327 [PubMed - as supplied by publisher]
	Comparison of lateral flank approach and low anterior access for single port (SP) retroperitoneal partial nephrectomy: an analysis from the single port advanced research consortium (SPARC). J Robot Surg Razdan S, Okhawere KE, Zuluaga L, Saini I, Ucpinar B, Sauer RC, Soputro N, Crivellaro S, Kaouk JH, Ahmed M, Stifelman MD, Badani KK. PMID: 38761306 [PubMed - indexed for MEDLINE]
	Targeting the autophagy-miRNA axis in prostate cancer: toward novel diagnostic and therapeutic strategies. Naunyn Schmiedebergs Arch Pharmacol Syed RU, Alshammari MD, Banu H, Khojali WMA, Jafar M, Nagaraju P, Alshammari A. PMID: 38761210 [PubMed - as supplied by publisher]
	Detection of two synchronous histologically different renal cell carcinoma subtypes in the same kidney:Â a case report and review of the literature. J Med Case Rep Sakr M, Badran M, Hassan SA, Elsaqa M, Elwany MA, Deeb NMFE, Sharafeldeen M. PMID: 38760853 [PubMed - indexed for MEDLINE]
	Association between metabolic syndrome and kidney cancer risk: a prospective cohort study. Lipids Health Dis Wang L, Du H, Sheng C, Dai H, Chen K. PMID: 38760801 [PubMed - indexed for MEDLINE]
	Immunophenotypic analysis of angiomyolipoma with epithelial cysts, comparison to mixed epithelial and stromal tumors and epithelial and stromal elements of normal kidney and ovaries. Virchows Arch Kilic I, Segura S, Ulbright TM, Mesa H. PMID: 38760593 [PubMed - as supplied by publisher]
	Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT. Sci Rep Rosar F, Burgard C, David S, Marlowe RJ, Bartholomä M, Maus S, Petto S, Khreish F, Schaefer-Schuler A, Ezziddin S. PMID: 38760451 [PubMed - indexed for MEDLINE]
	A population-based study on incidence trends of kidney and renal pelvis cancers in the United States over 2000-2020. Sci Rep Mousavi SE, Najafi M, Aslani A, Fazlollahi A, Yekta Z, Sadri M, Nejadghaderi SA. PMID: 38760399 [PubMed - indexed for MEDLINE]
	Re: Alonso Garcia-Ruiz, Carlos Macarro, Francesca Zacchi, et al. Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.016. Eur Urol Padhani AR, Lecouvet F, Petralia G, Koh DM. PMID: 38760293 [PubMed - as supplied by publisher]
	Reply to Anwar R. Padhani, Frederic LeCouvet, Giuseppe Petralia, and Dow-Mu Koh's Letter to the Editor re: Alonso Garcia-Ruiz, Carlos Macarro, Francesca Zacchi, et al. Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.016. Eur Urol Garcia-Ruiz A, Macarro C, Mateo J, Perez-Lopez R. PMID: 38760292 [PubMed - as supplied by publisher]
	Single-cell and bulk RNA-sequence identified fibroblasts signature and CD8+ T-cell - fibroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine-learning bioinformatics retrospective study. Int J Surg Li J, Kong Z, Qi Y, Wang W, Su Q, Huang W, Zhang Z, Li S, Du E. PMID: 38759695 [PubMed - as supplied by publisher]
	Trends in the global, regional, and national burden of testicular cancer from 1990 to 2019: an observational study with 30-year global data. Int J Surg Zhou X, Zhang Z, Ruan C, Wu Y, Zeng B, Su X, Yuan Q, Li Y, Wei Q, Qiu S. PMID: 38759694 [PubMed - as supplied by publisher]

Articles 1 - 20 / 170150

Page 1 of 8508



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy